5th Annual Liver Connect Conference
San Antonio, TX Start Date: March 21, 2025End Date: March 23, 2025HepQuant will participate in the 5th Annual Liver Connect Conference in San Antonio, TX. A silver sponsor of the event, the HepQuant team may be found at booth 17 in the exhibit hall. Three posters submitted by HepQuant will be featured during the conference.
- Poster 47: Initial Clinical Experience with the HepQuant DuO™ Test: Results from the 2023–2024 Early Access Program, Gordon, et al.
- Poster 22: Resmetirom Therapy of MASH-Associated Child Pugh A Cirrhosis Reduces Estimated Risk for Clinical Outcome Based on HepQuant RISK ACE Model, Imperial, et al.
- Poster 21: Pilot Study of a Model Based on Noninvasive Assessments of Portal-Systemic Shunting (HepQuant DuO), Hepatic Fibrosis (FibroScan), and Splenic Congestion (Platelet Count) for Accurate Prediction of Portal Hypertension and Clinically Significant Portal Hypertension, Imperial, et. al.